BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 18261960)

  • 1. Expression of tissue factor pathway inhibitor by endothelial cells and platelets.
    Maroney SA; Mast AE
    Transfus Apher Sci; 2008 Feb; 38(1):9-14. PubMed ID: 18261960
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glycosyl phosphatidylinositol anchorage of tissue factor pathway inhibitor.
    Zhang J; Piro O; Lu L; Broze GJ
    Circulation; 2003 Aug; 108(5):623-7. PubMed ID: 12835228
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protein S is a cofactor for platelet and endothelial tissue factor pathway inhibitor-α but not for cell surface-associated tissue factor pathway inhibitor.
    Wood JP; Ellery PE; Maroney SA; Mast AE
    Arterioscler Thromb Vasc Biol; 2014 Jan; 34(1):169-76. PubMed ID: 24233490
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A GPI-anchored co-receptor for tissue factor pathway inhibitor controls its intracellular trafficking and cell surface expression.
    Maroney SA; Cunningham AC; Ferrel J; Hu R; Haberichter S; Mansbach CM; Brodsky RA; Dietzen DJ; Mast AE
    J Thromb Haemost; 2006 May; 4(5):1114-24. PubMed ID: 16689766
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TFPIα and TFPIβ are expressed at the surface of breast cancer cells and inhibit TF-FVIIa activity.
    Stavik B; Tinholt M; Sletten M; Skretting G; Sandset PM; Iversen N
    J Hematol Oncol; 2013 Jan; 6():5. PubMed ID: 23320987
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Syndecan-3 and TFPI colocalize on the surface of endothelial-, smooth muscle-, and cancer cells.
    Tinholt M; Stavik B; Louch W; Carlson CR; Sletten M; Ruf W; Skretting G; Sandset PM; Iversen N
    PLoS One; 2015; 10(1):e0117404. PubMed ID: 25617766
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TFPIβ is the GPI-anchored TFPI isoform on human endothelial cells and placental microsomes.
    Girard TJ; Tuley E; Broze GJ
    Blood; 2012 Feb; 119(5):1256-62. PubMed ID: 22144186
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Localization of tissue factor pathway inhibitor to lipid rafts is not required for inhibition of factor VIIa/tissue factor activity.
    Dietzen DJ; Jack GG; Page KL; Tetzloff TA; Hall CL; Mast AE
    Thromb Haemost; 2003 Jan; 89(1):65-73. PubMed ID: 12540955
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Re-evaluation of mouse tissue factor pathway inhibitor and comparison of mouse and human tissue factor pathway inhibitor physiology.
    Girard TJ; Grunz K; Lasky NM; Malone JP; Broze GJ
    J Thromb Haemost; 2018 Nov; 16(11):2246-2257. PubMed ID: 30194803
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of the association of tissue factor pathway inhibitor with human placenta.
    Mast AE; Acharya N; Malecha MJ; Hall CL; Dietzen DJ
    Arterioscler Thromb Vasc Biol; 2002 Dec; 22(12):2099-104. PubMed ID: 12482841
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biology of tissue factor pathway inhibitor.
    Wood JP; Ellery PE; Maroney SA; Mast AE
    Blood; 2014 May; 123(19):2934-43. PubMed ID: 24620349
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Caveolae optimize tissue factor-Factor VIIa inhibitory activity of cell-surface-associated tissue factor pathway inhibitor.
    Maroney SA; Ellery PE; Wood JP; Ferrel JP; Bonesho CE; Mast AE
    Biochem J; 2012 Apr; 443(1):259-66. PubMed ID: 22239091
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cellular expression and biological activities of alternatively spliced forms of tissue factor pathway inhibitor.
    Maroney SA; Hansen KG; Mast AE
    Curr Opin Hematol; 2013 Sep; 20(5):403-9. PubMed ID: 23839295
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tissue factor pathway inhibitor: structure-function.
    Broze GJ; Girard TJ
    Front Biosci (Landmark Ed); 2012 Jan; 17(1):262-80. PubMed ID: 22201743
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reversible regulation of tissue factor-induced coagulation by glycosyl phosphatidylinositol-anchored tissue factor pathway inhibitor.
    Ott I; Miyagi Y; Miyazaki K; Heeb MJ; Mueller BM; Rao LV; Ruf W
    Arterioscler Thromb Vasc Biol; 2000 Mar; 20(3):874-82. PubMed ID: 10712416
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Active tissue factor pathway inhibitor is expressed on the surface of coated platelets.
    Maroney SA; Haberichter SL; Friese P; Collins ML; Ferrel JP; Dale GL; Mast AE
    Blood; 2007 Mar; 109(5):1931-7. PubMed ID: 17082321
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New insights into the biology of tissue factor pathway inhibitor.
    Maroney SA; Mast AE
    J Thromb Haemost; 2015 Jun; 13 Suppl 1(0 1):S200-7. PubMed ID: 26149025
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Murine hematopoietic cell tissue factor pathway inhibitor limits thrombus growth.
    Maroney SA; Cooley BC; Ferrel JP; Bonesho CE; Mast AE
    Arterioscler Thromb Vasc Biol; 2011 Apr; 31(4):821-6. PubMed ID: 21233452
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tissue factor pathway inhibitor (TFPI)--an update.
    Sandset PM
    Haemostasis; 1996 Oct; 26 Suppl 4():154-65. PubMed ID: 8979119
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tissue factor pathway inhibitor: then and now.
    Ellery PE; Adams MJ
    Semin Thromb Hemost; 2014 Nov; 40(8):881-6. PubMed ID: 25377319
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.